Top Markets
Coin of the day
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
Rangering i aksjer #29379
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
Aksjekurs
$3.86
Markedsverdi
$21.49M
Endring (1 dag)
-0.17%
Endring (1 år)
-25.27%
Land
JP
Handel Human Metabolome Technologies, Inc. (6090)

Kategori

Aksjeprishistorikk for Human Metabolome Technologies, Inc. (6090)
Høyeste sluttskurs: $3.90 den 2026-08-01

Laveste sluttskurs: $38.92 den 2013-12-01
Aksjeprishistorikk for Human Metabolome Technologies, Inc. fra 2013 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 6.42%
2025 5.53%
2024 -8.60%
2023 -16.34%
2022 -3.84%
2021 -27.40%
2020 -0.20%
2019 -31.00%
2018 -39.33%
2017 33.64%
2016 94.29%
2015 -35.63%
2014 -72.82%
2013 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH